Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health
problem, affecting up to a quarter of the world's adult population. The burden of NAFLD is …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is very common in the general
population, but identifying patients with increased risk of mortality and liver-specific morbidity …

Background Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver
disease worldwide. Asia is a large, heterogeneous area with substantial variation in …

Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …

Nonalcoholic fatty liver disease (NAFLD) is common and partially heritable and has no
effective treatments. We carried out a genome-wide association study (GWAS) meta …

Non-alcoholic fatty liver disease (NAFLD) encompasses pure steatosis through nonalcoholic
steatohepatitis (NASH) and is the most common cause of chronic liver disease in Western …

Despite the substantial gains in our understanding of NAFLD/NASH over the past 2
decades, there has been some dissatisfaction with the terminology “non‐alcoholic” which …

Ten years ago, few if any researchers in A sia showed interest in nonalcoholic fatty liver
disease (NAFLD). Today, NAFLD is increasingly recognized as a major chronic liver disease …

Whether nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of
mortality remains controversial. The present study aimed to clarify this issue. A systematic …